Induced-proximity target protein degradation (TPD) is a ground-breaking strategy in drug discovery that has emerged in the last decade. This CAS white paper surveys the research landscape, status of clinical trials, and discusses possible future opportunities.
With the widely publicized carbon emissions “race to zero” target by 2050 – interest has been increasing in carbon capture, storage and reduction technologies. Learn more in our landscape view of this emerging research with unique insights and a look at future opportunities.